Navigation Links
AlloSource Chosen as Healthcare Finalist in 2009 'Top Companies'
Date:8/7/2009

CENTENNIAL, Colo., Aug. 7 /PRNewswire/ -- AlloSource, one of the nation's largest non-profit providers of skin, bone and soft tissue allografts for use in surgical procedures, announced today that for the second consecutive year it has been selected as a finalist in the Healthcare category of the Top Company awards program hosted by ColoradoBiz magazine.

ColoradoBiz is hosting the business awards program for the 22nd consecutive year. The primary criteria for Top Company are sustained financial excellence, community involvement and operational excellence in one or more functional areas of the business.

In 2008, AlloSource saved and enhanced the lives of more people in more communities than ever before. The Company processed more than 4,150 tissue donors -- a 25% increase from 2007 -- whose gifts helped thousands of people to improve their mobility and functionality. This allowed AlloSource to provide 10% more allografts in 2008. Additionally, AlloSource processed more than 3,200 skin donors whose generous gifts helped save the lives of burn victims around the country.

"We are honored to again be recognized in our home state for our efforts to advance the uses of allograft tissue, which we distribute around the country to save and enhance lives," said Thomas A. Cycyota, AlloSource President and Chief Executive Officer. "Our recognition by the prestigious Top Company awards program is a testament to our success in our mission to honor the gift of donation and responsibly process and distribute human allograft tissue for our communities."

A judging panel of business and civic leaders is convened to vote on Top Company winners in each category. Judging will take place in mid-August. Top Company winners will be announced at an awards luncheon September 15 at the Seawell Ballroom, Denver Center for Performing Arts.


'/>"/>
SOURCE AlloSource
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Weber Shandwick Chosen By National Marrow Donor Program(R) To Head Awareness Campaign
2. Stem Cell Nutrition Company, STEMTech HealthSciences, Chosen as Finalist for Prestigious DSA Rising Star Award
3. TeleHealth Services chosen by HCA to Install Interactive Patient Education System in Timpanogos Regional Hospital
4. TeleHealth Services Chosen by HCA to Install Interactive Patient Education System in Timpanogos Regional Hospital
5. Dr. Adam Smith Chosen to Help Introduce No-Scar Surgical Weight-Loss Innovations
6. MassMutual Chosen as Full-Service Provider for LAMMICOs $10+ Million Retirement Plan
7. VARI researcher chosen for highly competitive Scholar-in-Training Award
8. TeleHealth Services Chosen by Baptist Hospital East in Development of New Park Tower
9. Elekta Chosen to Deliver Sophisticated Brain Mapping Technology to the Mind Research Network
10. Aurora Chosen as Preferred Provider for Workers on 2 Major State Road Projects
11. Lazarex Cancer Foundation Chosen as an Official Charity of Inaugural Rock N Roll Marathon in Seattle

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... ,, KANSASCITY,Mo.,Nov.25/PRNewswire/--TheBa...tion,slargestmedicalcliniconDec.9-10,whenKansasCit...nsuredpeople. ,, "Thisfreecliniceventhasthepote...wodaysinsteadofjustoneandbeheldonweekdaysinsteadof...asCityFreeHealthClinicandpresidentoftheNationalAss...
(Date:11/25/2009)... ,, SILVERSPRING,Md.,Nov.25/PRNewswire-USNew...eFDA,sCenterforDrugEvaluationandResearch,titled"AD...A,"appearsintheNov.26,2009issueofTheNewEnglandJour.../cgi-bin/prnh/20090824/FDALOGO ) ,, Inthearticl...enaccesstopainmedicationforthosewhoneeditandmanagi...
(Date:11/25/2009)... , Researchers have found evidence of a statistic...moxifen among patients whose estrogen receptor (ER...on of ER-alpha; at serine-118 (ER-alpha S118-P), a... November 25 in the Journal of the National Cance...inomas are resistant to tamoxifen. Preclinical stu...
(Date:11/25/2009)... , Evaluation and treatme... Woodstock (Vocus) November 25, 2009 ...1N1 nasal vaccines and H1N1 vaccine shots at four ...nce another shipment of vaccine has arrived. The c...stal Lake and McHenry and will be open as follows:...
(Date:11/25/2009)... ,, ARLINGTON,Va.,Nov.25/PRNewswire-USNewswi...ew"PreventHealthCareFraudActof2009,"S.2128,whichis...ilabletopreventfraudinMedicare.Thebillwasintroduce...containsseveralprovisionstheAmericanAssociationfor...whichtheAssociationproposedtoCongressinFebruary.Th...
Breaking Medicine News(10 mins):Health News:Kansas City Prepares for Largest Free Health Clinic 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 2Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 3Health News:Centegra H1N1 Vaccination Clinics to Resume Tuesday, Dec. 1 4Health News:American Association for Homecare Endorses New U.S. Senate Bill, the 'Prevent Health Care Fraud Act of 2009' 2
...fically press photographers have been suspected of...picion was unveiled// by a health official belongi...of our working hypotheses. Bird flu can be transmi... across the country,' said the health official. ...
...study conducted by India and Canada which was carr... research institute reported// a decrease in the H...15 to 24 years suffering from HIV in the states of...h Indian states. The four states account for ...
...for the elders to slip into the past and reminisce...th, but psychologists warn// that such frequent re...with the present. This phenomenon becomes a p...peating boring old yarns, it is not a normal sympt...
...ria and Tuberculosis in most developing countries ...opean Union, UNAIDS, WHO and the Indian Government...strategy against the diseases. "These diseas...he diseases in various countries," Mr.Alexander Sp...
...VT) or clot formation is on the rise among patient...r Liam Smeeth, from the London School of Hygiene a...ook at whether infection could trigger DVT or pulm...he London team found those who had suffered either...
...S. health regulators, gave their nod to the first ...tion in heart transplant patients.// The drug, ... to prevent rejection of liver and kidney transpla...ants in the U.S. each year will now have a new opt...
Other Medicine News:Health News:Reminiscing Into The Past Makes You Dissatisfied With The Present 2Health News:DVT Risk Increased After Acute Infections 2
(Date:11/25/2009)...TheFDAgrantedtraditionalapprovalforINTELENCE®...ptaseinhibitor(NNRTI).INTELENCEistheonlyNNRTIspeci...swhoareexperiencingvirologicfailurewithHIV-1strain...ts.Thetraditionalapprovalisbasedon48-weekdatafromt...urrentlymarketedintheU.S.byTibotecTherapeutics,adi...
(Date:11/25/2009)...-RegadoBiosciences,aprivatelyheldcompanyleadingthe...olagents,announcedthatDavidMazzo,PhD,CEOandPreside...thCareConferenceattheNewYorkPalaceHotelinNewYorkCi...nTuesday,December1andwillincludeanoverviewoftheCom...ram,theanticoagulantsystem,REG1.Thehealthcareindus...
(Date:11/25/2009)...rstCall/--Abaxis,Inc.(Nasdaq: ABAX ),amedicalprodu...ystems,announcedtodaythatClintSeverson,chairmanand...perJaffrayHealthCareConferenceonWednesday,December...YorkPalaceHotelinNewYorkCity. ,, AboutAbaxis ...ebloodanalysissystemsforuseinanyveterinaryorhumanp...
Breaking Medicine Technology:U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Beckman Coulter Announces Third Quarter 2009 Results 5858 1Beckman Coulter Announces Third Quarter 2009 Results 5858 2Beckman Coulter Announces Third Quarter 2009 Results 5858 3Beckman Coulter Announces Third Quarter 2009 Results 5858 4Beckman Coulter Announces Third Quarter 2009 Results 5858 5Beckman Coulter Announces Third Quarter 2009 Results 5858 6Beckman Coulter Announces Third Quarter 2009 Results 5858 7Beckman Coulter Announces Third Quarter 2009 Results 5858 8Beckman Coulter Announces Third Quarter 2009 Results 5858 9Beckman Coulter Announces Third Quarter 2009 Results 5858 10Beckman Coulter Announces Third Quarter 2009 Results 5858 11Beckman Coulter Announces Third Quarter 2009 Results 5858 12Beckman Coulter Announces Third Quarter 2009 Results 5858 13Beckman Coulter Announces Third Quarter 2009 Results 5858 14Beckman Coulter Announces Third Quarter 2009 Results 5858 15Beckman Coulter Announces Third Quarter 2009 Results 5858 16Beckman Coulter Announces Third Quarter 2009 Results 5858 17Beckman Coulter Announces Third Quarter 2009 Results 5858 18Beckman Coulter Announces Third Quarter 2009 Results 5858 19Beckman Coulter Announces Third Quarter 2009 Results 5858 20Beckman Coulter Announces Third Quarter 2009 Results 5858 21Beckman Coulter Announces Third Quarter 2009 Results 5858 22Beckman Coulter Announces Third Quarter 2009 Results 5858 23Beckman Coulter Announces Third Quarter 2009 Results 5858 24Beckman Coulter Announces Third Quarter 2009 Results 5858 25Beckman Coulter Announces Third Quarter 2009 Results 5858 26Beckman Coulter Announces Third Quarter 2009 Results 5858 27Beckman Coulter Announces Third Quarter 2009 Results 5858 28Beckman Coulter Announces Third Quarter 2009 Results 5858 29Beckman Coulter Announces Third Quarter 2009 Results 5858 30Beckman Coulter Announces Third Quarter 2009 Results 5858 31Beckman Coulter Announces Third Quarter 2009 Results 5858 32Beckman Coulter Announces Third Quarter 2009 Results 5858 33Beckman Coulter Announces Third Quarter 2009 Results 5858 34Beckman Coulter Announces Third Quarter 2009 Results 5858 35Additional Data from the Qnexa Phase 3 Studies Presented at The Obesity Society 27th Annual Scientific Meeting 5855 1Additional Data from the Qnexa Phase 3 Studies Presented at The Obesity Society 27th Annual Scientific Meeting 5855 2Additional Data from the Qnexa Phase 3 Studies Presented at The Obesity Society 27th Annual Scientific Meeting 5855 3Additional Data from the Qnexa Phase 3 Studies Presented at The Obesity Society 27th Annual Scientific Meeting 5855 4Additional Data from the Qnexa Phase 3 Studies Presented at The Obesity Society 27th Annual Scientific Meeting 5855 5Additional Data from the Qnexa Phase 3 Studies Presented at The Obesity Society 27th Annual Scientific Meeting 5855 6Additional Data from the Qnexa Phase 3 Studies Presented at The Obesity Society 27th Annual Scientific Meeting 5855 7Additional Data from the Qnexa Phase 3 Studies Presented at The Obesity Society 27th Annual Scientific Meeting 5855 8BioCryst to Present at Oppenheimer Healthcare Conference 5852 1BioCryst to Present at Oppenheimer Healthcare Conference 5852 2
...t. 18 Forest,Laboratories (NYSE: FRX ) announced...duced a significant bronchodilatory response in 17...e IIa trial presented today at the,European Respir...1) (Logo: http://www.newscom.com/cgi-bin/prnh/20...that mean FEV1 and FVC values - important,measures...
... http://www.wilsoncenter.org/globalhealth , WASHI...e W. Bush called for a reauthorization of the Pres...hich is set to expire at the end,of fiscal year 20... the,initial 2003 commitment of $15 billion to $30...20, 2007, the Woodrow Wilson Center,s Global Healt...
Other Medicine Technology:Study Results for Aclidinium Bromide, a Novel Anticholinergic, Presented at European Respiratory Society Annual Congress 2Study Results for Aclidinium Bromide, a Novel Anticholinergic, Presented at European Respiratory Society Annual Congress 3Study Results for Aclidinium Bromide, a Novel Anticholinergic, Presented at European Respiratory Society Annual Congress 4Study Results for Aclidinium Bromide, a Novel Anticholinergic, Presented at European Respiratory Society Annual Congress 5Director's Forum: PEPFAR and the Global AIDS Response 2
...the user to quickly and accurately count bacteria ...unting or manual counting. An optional 1.5X auxili...gnification to 3.0X. The adjustable focusing rod a...ed. The lens also rotates a full 360 for ready acc...
...the user to quickly and accurately count bacteria ...unting or manual counting. An optional 1.5X auxili...gnification to 3.0X. The adjustable focusing rod a...ed. The lens also rotates a full 360 for ready acc...
Accucount 2000 (115V/60Hz)
Accucount 1000 (115V/60Hz)
Medicine Products: